Stay updated with breaking news from Versaptx Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily pretreated patients with metastatic solid tumors
Investigators from the National Institutes of Health report 2 partial responses in 3 peripheral T-cell lymphoma patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma patients in ongoing...
Investigators from the National Institutes of Health (NIH) report 2 partial responses (PR) in 3 peripheral T-cell lymphoma (PTCL) patients and 1 P...